Dependence receptors: new targets for cancer therapy
Abstract Dependence receptors are known to promote survival and positive signaling such as proliferation, migration, and differentiation when activated, but to actively trigger apoptosis when unbound to their ligand. Their abnormal regulation was shown to be an important feature of tumorigenesis, al...
Main Authors: | Morgan Brisset, Mélodie Grandin, Agnès Bernet, Patrick Mehlen, Frédéric Hollande |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2021-11-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.202114495 |
Similar Items
-
Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity
by: Morgan Brisset, et al.
Published: (2023-10-01) -
Promising Antineoplastic Actions of Melatonin
by: Gaia Favero, et al.
Published: (2018-10-01) -
Emerging Lipid Targets in Glioblastoma
by: Ammar Darwish, et al.
Published: (2024-01-01) -
Tumor acidity: From hallmark of cancer to target of treatment
by: Alexey Bogdanov, et al.
Published: (2022-08-01) -
Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
by: Ulrich T. Hacker, et al.
Published: (2020-07-01)